Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ILLUMINA, INC.ILMN · Entity 3137 | Director | May 21, 2026 | May 22, 2026 |
| PFIZER INCPFE · Entity 2863 | Director | April 23, 2026 | April 27, 2026 |
| Tempus AI, Inc.TEM · Entity 1545 | Director | May 21, 2026 | May 27, 2026 |
| UNITEDHEALTH GROUP INCUNH · Entity 2809 | Director | October 01, 2026 | October 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ILLUMINA, INC.
Report date May 21, 2026 · Filed May 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 14,795 |
Reported balance
After 2026-05-21 transaction · row 1
1 source rowRow 1 · 2026-05-21 · Grant · Acquired 2,072 · Balance 14,795 F1: Grant of restricted stock units. 100% of the shares subject to the restricted stock unit award shall vest the date prior to the annual meeting of the company's stockholders in the year of the award, provided, in each case, that the awardee continues to serve as a director on such date. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of restricted stock units. 100% of the shares subject to the restricted stock unit award shall vest the date prior to the annual meeting of the company's stockholders in the year of the award, provided, in each case, that the awardee continues to serve as a director on such date.
PFIZER INC
Report date April 23, 2026 · Filed April 27, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom Stock UnitsSEC Table II · derivative / convertible security | Direct | 57,001.814 |
Reported balance
After 2026-04-23 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-04-23 · Grant · Acquired 7,686.539 · Balance 57,001.814 F1: Each unit represents one phantom share of common stock. F2: Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors. F3: These units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors. |
Filing footnotes · ownership attribution and instrument terms
F1: Each unit represents one phantom share of common stock.
F2: Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors.
F3: These units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors.
Tempus AI, Inc.
Report date May 21, 2026 · Filed May 27, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Comnmon StockSEC Table I · non-derivative | Direct | 40,749 |
Reported balance
After 2026-05-21 transaction · row 1
1 source rowRow 1 · 2026-05-21 · Grant · Acquired 5,913 · Balance 40,749 F1: Represents a restricted stock unit ("RSU") award. The RSUs will vest in full on the earlier of (i) the date of the Issuer's 2027 annual meeting of the stockholders (or the date immediately prior to such annual meeting if the Reporting Person's service as a director ends at such annual meeting) or (ii) on May 21, 2027, each subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a restricted stock unit ("RSU") award. The RSUs will vest in full on the earlier of (i) the date of the Issuer's 2027 annual meeting of the stockholders (or the date immediately prior to such annual meeting if the Reporting Person's service as a director ends at such annual meeting) or (ii) on May 21, 2027, each subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date.
UNITEDHEALTH GROUP INC
Report date October 01, 2026 · Filed October 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 921 |
Reported balance
After 2026-10-01 transaction · row 1
1 source rowRow 1 · 2026-10-01 · Grant · Acquired 257 · Balance 921 F1: Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until the director's completion of service on the Board. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until the director's completion of service on the Board.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 01, 2026 Filed Oct 5, 2026 20:25 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | GrantCommon Stock | 257 | $0.00 | $0.00 |
DisclosureSEC source: 0000731766-26-000250 · wk-form4_1791231905.xml · nonDerivative · entry 1 Gottlieb Scott · CIK 0001411359 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 921 F1 · shares: Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until the director's completion of service on the Board. Read SEC document |
| September 22, 2026 Filed Sep 24, 2026 20:13 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | GrantCommon Stock | 5 | $0.00 | $0.00 |
DisclosureSEC source: 0000731766-26-000230 · wk-form4_1790280797.xml · nonDerivative · entry 1 Gottlieb Scott · CIK 0001411359 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 664 F1 · shares: Represents dividend equivalents paid on vested deferred stock units. The dividend equivalents are immediately vested and are subject to the same terms as the underlying deferred stock units. Read SEC document |
| July 01, 2026 Filed Jul 6, 2026 20:44 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | GrantCommon Stock | 210 | $0.00 | $0.00 |
DisclosureSEC source: 0000731766-26-000183 · wk-form4_1783370697.xml · nonDerivative · entry 1 Gottlieb Scott · CIK 0001411359 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 659 F1 · shares: Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until the director's completion of service on the Board. Read SEC document |
| June 23, 2026 Filed Jun 25, 2026 21:37 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | GrantCommon Stock | 3 | $0.00 | $0.00 |
DisclosureSEC source: 0000731766-26-000168 · wk-form4_1782423468.xml · nonDerivative · entry 1 Gottlieb Scott · CIK 0001411359 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 449 F1 · shares: Represents dividend equivalents paid on vested deferred stock units. The dividend equivalents are immediately vested and are subject to the same terms as the underlying deferred stock units. Read SEC document |
| May 21, 2026 Filed May 22, 2026 21:09 UTC | ILLUMINA, INC. ILMN · Entity 3137 | GrantCommon Stock | 2,072 | $144.83 | $300,087.76 |
DisclosureSEC source: 0001110803-26-000115 · form4.xml · nonDerivative · entry 1 Gottlieb Scott · CIK 0001411359 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,795 F1 · shares: Grant of restricted stock units. 100% of the shares subject to the restricted stock unit award shall vest the date prior to the annual meeting of the company's stockholders in the year of the award, provided, in each case, that the awardee continues to serve as a director on such date. Read SEC document |
| May 21, 2026 Filed May 27, 2026 01:45 UTC | Tempus AI, Inc. TEM · Entity 1545 | GrantClass A Comnmon Stock | 5,913 | $0.00 | $0.00 |
DisclosureSEC source: 0001411359-26-000002 · form4-05262026_090509.xml · nonDerivative · entry 1 Gottlieb Scott · CIK 0001411359 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,749 F1 · shares: Represents a restricted stock unit ("RSU") award. The RSUs will vest in full on the earlier of (i) the date of the Issuer's 2027 annual meeting of the stockholders (or the date immediately prior to such annual meeting if the Reporting Person's service as a director ends at such annual meeting) or (ii) on May 21, 2027, each subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date. Read SEC document |
| April 23, 2026 Filed Apr 27, 2026 22:40 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units · Derivative | 7,686.539 | $26.67 | $205,000.00 |
DisclosureSEC source: 0001225208-26-004663 · doc4.xml · derivative · entry 1 Gottlieb Scott · CIK 0001411359 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,001.814 Underlying: Common Stock · 7,686.539 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · shares: Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors. F3 · derivative.exercise_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors. F3 · derivative.expiration_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors. Read SEC document |
| April 01, 2026 Filed Apr 6, 2026 21:04 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | GrantCommon Stock | 320 | $0.00 | $0.00 |
DisclosureSEC source: 0000731766-26-000113 · wk-form4_1775509452.xml · nonDerivative · entry 1 Gottlieb Scott · CIK 0001411359 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 446 F1 · shares: Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until the director's completion of service on the Board. Read SEC document |
| March 17, 2026 Filed Mar 19, 2026 20:32 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | GrantCommon Stock | 1 | $0.00 | $0.00 |
DisclosureSEC source: 0000731766-26-000087 · wk-form4_1773952355.xml · nonDerivative · entry 1 Gottlieb Scott · CIK 0001411359 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 126 F1 · shares: Represents dividend equivalents paid on vested deferred stock units. The dividend equivalents are immediately vested and are subject to the same terms as the underlying deferred stock units. Read SEC document |
| February 09, 2026 Filed Feb 11, 2026 21:04 UTC | ILLUMINA, INC. ILMN · Entity 3137 | PurchaseCommon Stock | 200 | $117.81 | $23,562.00 |
DisclosureSEC source: 0001110803-26-000022 · form4.xml · nonDerivative · entry 1 Gottlieb Scott · CIK 0001411359 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,723 Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 23:20 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | GrantCommon Stock | 125 | $0.00 | $0.00 |
DisclosureSEC source: 0000731766-26-000013 · wk-form4_1767741610.xml · nonDerivative · entry 1 Gottlieb Scott · CIK 0001411359 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125 F1 · shares: Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until the director's completion of service on the Board. Read SEC document |
| November 03, 2025 Filed Nov 5, 2025 21:05 UTC | ILLUMINA, INC. ILMN · Entity 3137 | PurchaseCommon Stock | 500 | $122.13 | $61,065.00 |
DisclosureSEC source: 0001110803-25-000076 · form4.xml · nonDerivative · entry 1 Gottlieb Scott · CIK 0001411359 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,523 Read SEC document |
| May 21, 2025 Filed May 23, 2025 21:07 UTC | ILLUMINA, INC. ILMN · Entity 3137 | GrantCommon Stock | 3,780 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-015511 · form4.xml · nonDerivative · entry 1 Gottlieb Scott · CIK 0001411359 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,023 F1 · shares: Grant of restricted stock units. 100% of the shares subject to the restricted stock unit award shall vest on the earlier of (i) the one year anniversary of the date of grant of the award and (ii) the date immediately preceding the date of the annual meeting of the company's stockholders for the year following the year of grant of the award, provided, in each case, that the awardee continues to serve as a director on such date. F2 · balance_after: In connection with Illumina's spin out of Grail, Inc., which was completed on June 24, 2024, all unvested equity award units were adjusted pursuant to Illumina's Amended and Restated 2015 Stock and Incentive Plan. Dr. Gottlieb's unvested RSUs were increased by 53 units as a result of such adjustment. Read SEC document |
| May 20, 2025 Filed May 23, 2025 00:00 UTC | Tempus AI, Inc. TEM · Entity 1545 | GrantClass A Comnmon Stock | 1,997 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-014309 · form4-05222025_080524.xml · nonDerivative · entry 1 Gottlieb Scott · CIK 0001411359 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,836 F1 · shares: Represents a restricted stock unit ("RSU") award. The RSUs will vest in full on the earlier of (i) the date of the Issuer's 2026 annual meeting of the stockholders (or the date immediately prior to such annual meeting if the Reporting Person's service as a director ends at such annual meeting) or (ii) on May 20, 2026, each subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date. Read SEC document |
| April 24, 2025 Filed Apr 28, 2025 15:53 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units · Derivative | 8,999 | $22.78 | $204,997.22 |
DisclosureSEC source: 0001225208-25-004459 · doc4.xml · derivative · entry 1 Gottlieb Scott · CIK 0001411359 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,115.482 Underlying: Common Stock · 8,999 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · shares: Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors. F3 · derivative.exercise_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. F3 · derivative.expiration_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 21:30 UTC | Tempus AI, Inc. TEM · Entity 1545 | SaleClass A Common Stock | 2,558 | $48.69 | $124,549.02 |
DisclosureSEC source: 0001415889-25-010020 · form4-04032025_090458.xml · nonDerivative · entry 4 Gottlieb Scott · CIK 0001411359 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,839 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 27, 2024. F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.56 to $49.04 inclusive. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 21:30 UTC | Tempus AI, Inc. TEM · Entity 1545 | SaleClass A Common Stock | 4,000 | $48.13 | $192,520.00 |
DisclosureSEC source: 0001415889-25-010020 · form4-04032025_090458.xml · nonDerivative · entry 3 Gottlieb Scott · CIK 0001411359 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 35,397 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 27, 2024. F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.55 to $47.53 inclusive. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 21:30 UTC | Tempus AI, Inc. TEM · Entity 1545 | SaleClass A Common Stock | 16,273 | $47.10 | $766,458.30 |
DisclosureSEC source: 0001415889-25-010020 · form4-04032025_090458.xml · nonDerivative · entry 2 Gottlieb Scott · CIK 0001411359 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 39,397 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 27, 2024. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.55 to $47.53 inclusive. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 21:30 UTC | Tempus AI, Inc. TEM · Entity 1545 | SaleClass A Common Stock | 5,006 | $46.07 | $230,626.42 |
DisclosureSEC source: 0001415889-25-010020 · form4-04032025_090458.xml · nonDerivative · entry 1 Gottlieb Scott · CIK 0001411359 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 55,670 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 27, 2024. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.55 to $46.54 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4) and (5). Read SEC document |
| March 17, 2025 Filed Mar 19, 2025 22:30 UTC | Tempus AI, Inc. TEM · Entity 1545 | SaleClass A Common Stock | 7,102 | $50.45 | $358,295.90 |
DisclosureSEC source: 0001415889-25-008654 · form4-03192025_060306.xml · nonDerivative · entry 5 Gottlieb Scott · CIK 0001411359 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 60,676 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 27, 2024, and was made in part to cover applicable tax obligations arising in connection with the vesting and settlement of restricted stock units. F6 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.12 to $50.81 inclusive. Read SEC document |
| March 17, 2025 Filed Mar 19, 2025 22:30 UTC | Tempus AI, Inc. TEM · Entity 1545 | SaleClass A Common Stock | 6,698 | $49.72 | $333,024.56 |
DisclosureSEC source: 0001415889-25-008654 · form4-03192025_060306.xml · nonDerivative · entry 4 Gottlieb Scott · CIK 0001411359 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 67,778 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 27, 2024, and was made in part to cover applicable tax obligations arising in connection with the vesting and settlement of restricted stock units. F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.12 to $50.11 inclusive. Read SEC document |
| March 17, 2025 Filed Mar 19, 2025 22:30 UTC | Tempus AI, Inc. TEM · Entity 1545 | SaleClass A Common Stock | 6,349 | $48.44 | $307,545.56 |
DisclosureSEC source: 0001415889-25-008654 · form4-03192025_060306.xml · nonDerivative · entry 3 Gottlieb Scott · CIK 0001411359 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 74,476 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 27, 2024, and was made in part to cover applicable tax obligations arising in connection with the vesting and settlement of restricted stock units. F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.08 to $49.07 inclusive. Read SEC document |
| March 17, 2025 Filed Mar 19, 2025 22:30 UTC | Tempus AI, Inc. TEM · Entity 1545 | SaleClass A Common Stock | 3,077 | $47.53 | $146,249.81 |
DisclosureSEC source: 0001415889-25-008654 · form4-03192025_060306.xml · nonDerivative · entry 2 Gottlieb Scott · CIK 0001411359 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 80,825 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 27, 2024, and was made in part to cover applicable tax obligations arising in connection with the vesting and settlement of restricted stock units. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.08 to $48.00 inclusive. Read SEC document |
| March 17, 2025 Filed Mar 19, 2025 22:30 UTC | Tempus AI, Inc. TEM · Entity 1545 | SaleClass A Common Stock | 4,612 | $46.59 | $214,873.08 |
DisclosureSEC source: 0001415889-25-008654 · form4-03192025_060306.xml · nonDerivative · entry 1 Gottlieb Scott · CIK 0001411359 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 83,902 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 27, 2024, and was made in part to cover applicable tax obligations arising in connection with the vesting and settlement of restricted stock units. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.06 to $47.05 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5) and (6). Read SEC document |
| October 30, 2024 Filed Oct 31, 2024 20:06 UTC | PFIZER INC PFE · Entity 2863 | PurchaseCommon Stock | 1,000 | $28.24 | $28,240.00 |
DisclosureSEC source: 0001225208-24-009545 · doc4.xml · nonDerivative · entry 1 Gottlieb Scott · CIK 0001411359 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Read SEC document |
| June 13, 2024 Filed Jun 18, 2024 01:45 UTC | Tempus AI, Inc. TEM · Entity 1545 | GrantClass A Common Stock | 88,514 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-017309 · form4-06172024_090618.xml · nonDerivative · entry 1 Gottlieb Scott · CIK 0001411359 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,514 F1 · shares: Consists of previously granted restricted stock units ("RSUs") for which the liquidity event-based condition was satisfied upon the effectiveness of the registration statement on Form S-1 filed by the Issuer in connection with the Issuer's initial public offering, as well as, a grant of RSUs made in connection with the Issuer's Non-Employee Director Compensation Policy. Certain of the RSUs remain subject to service-based vesting conditions, as follows: (i) 25,000 RSUs one-fifth of which vest on July 1, 2024 with the remainder vesting in 16 equal quarterly installments commencing on October 1, 2024 and (ii) 13,514 RSUs vest in 20 substantially equal quarterly installments commencing on September 13, 2024. Read SEC document |
| May 16, 2024 Filed May 17, 2024 22:16 UTC | ILLUMINA, INC. ILMN · Entity 3137 | GrantCommon Stock | 2,622 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-015930 · form4.xml · nonDerivative · entry 1 Gottlieb Scott · CIK 0001411359 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,190 F1 · shares: Grant of restricted stock units. 100% of the shares subject to the restricted stock unit award shall vest on the earlier of (i) the one year anniversary of the date of grant of the award and (ii) the date immediately preceding the date of the annual meeting of the company's stockholders for the year following the year of grant of the award, provided, in each case, that the awardee continues to serve as a director on such date. Read SEC document |
| April 25, 2024 Filed Apr 26, 2024 17:23 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units · Derivative | 8,115.598 | $25.26 | $205,000.01 |
DisclosureSEC source: 0001225208-24-005270 · doc4.xml · derivative · entry 1 Gottlieb Scott · CIK 0001411359 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,886.291 Underlying: Common Stock · 8,115.598 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · shares: Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors. F3 · derivative.exercise_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. F3 · derivative.expiration_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. Read SEC document |
| December 29, 2023 Filed Jan 2, 2024 21:06 UTC | ILLUMINA, INC. ILMN · Entity 3137 | GrantCommon Stock | 220 | $113.48 | $24,965.58 |
DisclosureSEC source: 0001127602-24-000103 · form4.xml · nonDerivative · entry 1 Gottlieb Scott · CIK 0001411359 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,568 F1 · shares: Dr. Gottlieb elected to receive 100% of his 2023 board and committee cash retainer fees in Illumina stock. The number of shares issued in lieu of cash is based on the quotient of (i) the cash compensation otherwise payable for the immediately completed quarter divided by (ii) the volume weighted average closing price per share during the immediately completed quarter, calculated by reference to each trading day during such quarter. The amount reported on this Form represents Dr. Gottlieb's 4th quarter 2023 retainer fees. Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 14:31 UTC | PFIZER INC PFE · Entity 2863 | PurchaseCommon Stock | 3,000 | $26.47 | $79,401.00 |
DisclosureSEC source: 0001225208-23-011250 · doc4.xml · nonDerivative · entry 1 Gottlieb Scott · CIK 0001411359 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,000 Read SEC document |
| September 29, 2023 Filed Oct 3, 2023 21:59 UTC | ILLUMINA, INC. ILMN · Entity 3137 | GrantCommon Stock | 142 | $166.74 | $23,677.46 |
DisclosureSEC source: 0001127602-23-025340 · form4.xml · nonDerivative · entry 1 Gottlieb Scott · CIK 0001411359 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,348 F1 · shares: Dr. Gottlieb elected to receive 100% of his 2023 board and committee cash retainer fees in Illumina stock. The number of shares issued in lieu of cash is based on the quotient of (i) the cash compensation otherwise payable for the immediately completed quarter divided by (ii) the volume weighted average closing price per share during the immediately completed quarter, calculated by reference to each trading day during such quarter. The amount reported on this Form represents Dr. Gottlieb's 3rd quarter 2023 retainer fees. Read SEC document |
| June 30, 2023 Filed Jul 3, 2023 21:18 UTC | ILLUMINA, INC. ILMN · Entity 3137 | GrantCommon Stock | 103 | $205.79 | $21,195.94 |
DisclosureSEC source: 0001127602-23-019762 · form4.xml · nonDerivative · entry 1 Gottlieb Scott · CIK 0001411359 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,206 F1 · shares: Dr. Gottlieb elected to receive 100% of his 2023 board and committee cash retainer fees in Illumina stock. The number of shares issued in lieu of cash is fixed at the end of each calendar quarter based on the volume weighted average closing price of Illumina common stock of $205.7858 during such calendar quarter. The amount reported on this Form represents Dr. Gottlieb's second quarter 2023 retainer fees. Read SEC document |
| May 26, 2023 Filed May 31, 2023 20:58 UTC | ILLUMINA, INC. ILMN · Entity 3137 | GrantCommon Stock | 1,532 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-017239 · form4.xml · nonDerivative · entry 1 Gottlieb Scott · CIK 0001411359 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,103 F1 · shares: Grant of restricted stock units. 100% of the shares subject to the restricted stock unit award shall vest on the earlier of (i) the one year anniversary of the date of grant of the award and (ii) the date immediately preceding the date of the annual meeting of the company's stockholders for the year following the year of grant of the award, provided, in each case, that the awardee continues to serve as a director on such date. Read SEC document |
| May 08, 2023 Filed May 9, 2023 20:17 UTC | PFIZER INC PFE · Entity 2863 | PurchaseCommon Stock | 1,000 | $38.58 | $38,580.00 |
DisclosureSEC source: 0001225208-23-005604 · doc4.xml · nonDerivative · entry 2 Gottlieb Scott · CIK 0001411359 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,000 Read SEC document |
| May 05, 2023 Filed May 9, 2023 20:17 UTC | PFIZER INC PFE · Entity 2863 | PurchaseCommon Stock | 1,000 | $38.43 | $38,425.00 |
DisclosureSEC source: 0001225208-23-005604 · doc4.xml · nonDerivative · entry 1 Gottlieb Scott · CIK 0001411359 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000 Read SEC document |
| April 27, 2023 Filed Apr 28, 2023 20:33 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units · Derivative | 5,291.688 | $38.74 | $204,999.99 |
DisclosureSEC source: 0001225208-23-005149 · doc4.xml · derivative · entry 1 Gottlieb Scott · CIK 0001411359 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,425.24 Underlying: Common Stock · 5,291.688 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · shares: Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors. F3 · derivative.exercise_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. F3 · derivative.expiration_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 20:14 UTC | ILLUMINA, INC. ILMN · Entity 3137 | GrantCommon Stock | 100 | $210.47 | $21,047.38 |
DisclosureSEC source: 0001127602-23-012178 · form4.xml · nonDerivative · entry 1 Gottlieb Scott · CIK 0001411359 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,571 F1 · shares: Dr. Gottlieb elected to receive 100% of his 2023 board and committee cash retainer fees in Illumina stock. The number of shares issued in lieu of cash is fixed at the end of each calendar quarter based on the volume weighted average closing price of Illumina common stock of $210.4738 during such calendar quarter. The amount reported on this Form represents Dr. Gottlieb's first quarter 2023 retainer fees. Read SEC document |
| May 26, 2022 Filed May 27, 2022 23:35 UTC | ILLUMINA, INC. ILMN · Entity 3137 | GrantCommon Stock | 1,232 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-015921 · form4.xml · nonDerivative · entry 1 Gottlieb Scott · CIK 0001411359 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,471 F1 · shares: Grant of restricted stock units. 100% of the shares subject to the restricted stock unit award shall vest on the earlier of (i) the one year anniversary of the date of grant of the award and (ii) the date immediately preceding the date of the annual meeting of the company's stockholders for the year following the year of grant of the award, provided, in each case, that the awardee continues to serve as a director on such date. Read SEC document |
| April 28, 2022 Filed Apr 29, 2022 20:17 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units · Derivative | 4,058.602 | $50.51 | $204,999.99 |
DisclosureSEC source: 0001225208-22-006288 · doc4.xml · derivative · entry 1 Gottlieb Scott · CIK 0001411359 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,451.872 Underlying: Common Stock · 4,058.602 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · shares: Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors. F3 · derivative.exercise_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. F3 · derivative.expiration_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. Read SEC document |
| May 26, 2021 Filed May 27, 2021 21:37 UTC | ILLUMINA, INC. ILMN · Entity 3137 | GrantCommon Stock | 881 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-018209 · form4.xml · nonDerivative · entry 1 Gottlieb Scott · CIK 0001411359 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,239 F1 · security: Grant of restricted stock units. 100% of the shares subject to the restricted stock unit award shall vest on the earlier of (i) the one year anniversary of the date of grant of the award and (ii) the date immediately preceding the date of the annual meeting of the company's stockholders for the year following the year of grant of the award, provided, in each case, that the awardee continues to serve as a director on such date. Read SEC document |
| April 22, 2021 Filed Apr 23, 2021 18:02 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units · Derivative | 4,981.884 | $38.64 | $192,500.00 |
DisclosureSEC source: 0001225208-21-006943 · doc4.xml · derivative · entry 1 Gottlieb Scott · CIK 0001411359 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,879.357 Underlying: Common Stock · 4,981.884 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · shares: Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors. F3 · derivative.exercise_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. F3 · derivative.expiration_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. Read SEC document |
| May 27, 2020 Filed May 28, 2020 22:06 UTC | ILLUMINA, INC. ILMN · Entity 3137 | GrantCommon Stock | 963 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-018083 · form4.xml · nonDerivative · entry 1 Gottlieb Scott · CIK 0001411359 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,358 F1 · security: Grant of restricted stock units. 100% of the shares subject to the restricted stock unit award shall vest on the earlier of (i) the one year anniversary of the date of grant of the award and (ii) the date immediately preceding the date of the annual meeting of the company's stockholders for the year following the year of grant of the award, provided, in each case, that the awardee continues to serve as a director on such date. Read SEC document |
| April 23, 2020 Filed Apr 24, 2020 19:38 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units · Derivative | 5,246.661 | $36.69 | $192,499.99 |
DisclosureSEC source: 0001225208-20-006706 · doc4.xml · derivative · entry 1 Gottlieb Scott · CIK 0001411359 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,023.811 Underlying: Common Stock · 5,246.661 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · shares: Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors. F3 · derivative.exercise_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. F3 · derivative.expiration_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. Read SEC document |
| February 04, 2020 Filed Feb 6, 2020 22:19 UTC | ILLUMINA, INC. ILMN · Entity 3137 | GrantCommon Stock | 395 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-004037 · form4.xml · nonDerivative · entry 1 Gottlieb Scott · CIK 0001411359 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 395 F1 · shares: Grant of restricted stock units. 100% of the shares subject to the restricted stock unit award shall vest the date prior to the annual meeting of the company's stockholders in the year of the award, provided, in each case, that the awardee continues to serve as a director on such date. Read SEC document |
| January 30, 2020 Filed Jan 31, 2020 13:06 UTC | PFIZER INC PFE · Entity 2863 | PurchaseCommon Stock | 1,000 | $37.00 | $36,996.60 |
DisclosureSEC source: 0001225208-20-001364 · doc4.xml · nonDerivative · entry 1 Gottlieb Scott · CIK 0001411359 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Read SEC document |
| August 23, 2019 Filed Aug 26, 2019 13:27 UTC | PFIZER INC PFE · Entity 2863 | PurchaseCommon Stock | 3,000 | $34.72 | $104,160.00 |
DisclosureSEC source: 0001225208-19-011847 · doc4.xml · nonDerivative · entry 1 Gottlieb Scott · CIK 0001411359 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Read SEC document |
| June 27, 2019 Filed Jul 1, 2019 22:48 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units · Derivative | 3,665.27 | $43.43 | $159,182.68 |
DisclosureSEC source: 0001225208-19-009708 · doc4.xml · derivative · entry 1 Gottlieb Scott · CIK 0001411359 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,665.27 Underlying: Common Stock · 3,665.27 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors. F2 · derivative.expiration_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.